These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38250857)

  • 21. Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
    Lin DY; Gu Y; Xu Y; Wheeler B; Young H; Sunny SK; Moore Z; Zeng D
    JAMA; 2022 Oct; 328(14):1415-1426. PubMed ID: 36155617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers.
    Brunner WM; Freilich D; Victory J; Krupa N; Scribani MB; Jenkins P; Lasher EG; Fink A; Shah A; Cross P; Bush V; Peek LJ; Pestano GA; Gadomski AM
    Int J Infect Dis; 2022 Oct; 123():183-191. PubMed ID: 36044963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
    Hyun H; Jang AY; Park H; Heo JY; Seo YB; Nham E; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ; Yoon SY; Seok JH; Kim J; Park MS; Song JY
    Front Immunol; 2023; 14():1131229. PubMed ID: 36960070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study.
    Martín-Iguacel R; Pericas C; Bruguera A; Rosell G; Martínez E; Díaz Y; Alonso L; Nomah DK; Blanco JL; Domingo P; Álvarez-López P; Linares MS; Vilades Laborda C; Mera A; Calzado Isbert S; Johansen IS; Miró JM; Casabona J; Llibre JM;
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.
    Teran RA; Gagner A; Gretsch S; Lauritsen J; Galanto D; Walblay K; Ruestow P; Korban C; Pacilli M; Kern D; Black SR; Tabidze I
    Emerg Infect Dis; 2023 Nov; 29(11):2257-2265. PubMed ID: 37877555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV.
    Griffin DWJ; Pai Mangalore R; Hoy JF; McMahon JH
    AIDS; 2023 Jul; 37(9):1345-1360. PubMed ID: 37070539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts.
    Park LS; McGinnis KA; Gordon KS; Justice AC; Leyden W; Silverberg MJ; Skarbinski J; Jefferson C; Horberg M; Certa J; Napravnik S; Edwards JK; Westreich D; Bastarache L; Gangireddy S; Benning L; D'Souza G; Williams C; Althoff KN;
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):249-255. PubMed ID: 35195574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine.
    Schmidt KG; Harrer EG; Schönau V; Simon D; Kleyer A; Steininger P; Korn K; Schett G; Knobloch CS; Nganou-Makamdop K; Harrer T
    Infection; 2023 Dec; 51(6):1657-1667. PubMed ID: 37067754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022.
    Chatzilena A; Hyams C; Challen R; Marlow R; King J; Adegbite D; Kinney J; Clout M; Maskell N; Oliver J; Finn A; Danon L;
    Euro Surveill; 2023 Nov; 28(48):. PubMed ID: 38037728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era.
    Ioannou GN; Bohnert ASB; O'Hare AM; Boyko EJ; Maciejewski ML; Smith VA; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM; Berry K;
    Ann Intern Med; 2022 Dec; 175(12):1693-1706. PubMed ID: 36215715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 vaccine uptake among people with HIV: identifying characteristics associated with vaccine hesitancy.
    Boschung K; Gill MJ; Krentz HB; Dalere J; Beckthold B; Fonseca K; Bakal JA; McMillan JM; Kanji J; Lang R
    Sci Rep; 2023 Nov; 13(1):20610. PubMed ID: 37996521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse events and SARS-CoV-2 antibody responses after immunization with Sputnik V, ChAdOx1-S, and BBIBP-CorV vaccines in people with HIV.
    Mauas R; Urueña A; Cecchini D; Strada ML; Arietti S; Cassetti I; Nogueira NF; Salazar AS; Rodriguez VJ; Jones DL; Alcaide ML
    AIDS; 2023 May; 37(6):941-946. PubMed ID: 36728228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral and Cellular Immune Response Elicited by Two Doses of mRNA BNT162b2 Vaccine Against SARS-CoV-2 in People Living with HIV.
    Vanetti C; Milazzo L; Ardizzone F; Oreni L; Cappelletti G; Trabattoni D; Biasin M
    AIDS Res Hum Retroviruses; 2023 Sep; 39(9):495-499. PubMed ID: 37031355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically recognized sleep disorders in people living with HIV.
    Lam JO; Hou CE; Alexeeff S; Levine T; Sarovar V; Lea AN; Metz VE; Horberg MA; Satre DD; Silverberg MJ
    HIV Med; 2024 Oct; 25(10):1162-1168. PubMed ID: 38890008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.
    Opsteen S; Fram T; Files JK; Levitan EB; Goepfert P; Erdmann N
    J Acquir Immune Defic Syndr; 2024 May; 96(1):92-100. PubMed ID: 38408318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2.
    Pourcher V; Belin L; Soulie C; Rosenzwajg M; Marot S; Lacombe K; Valin N; Pialoux G; Calin R; Palacios C; Malet I; Zafilaza K; Tubiana R; Valantin MA; Klatzmann D; Calvez V; Simon-Tillaux N; Marcelin AG
    AIDS; 2022 Sep; 36(11):1545-1552. PubMed ID: 35730380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimorbidity Burden and Incident Heart Failure Among People With and Without HIV: The HIV-HEART Study.
    Mefford MT; Silverberg MJ; Leong TK; Hechter RC; Towner WJ; Go AS; Horberg M; Hu H; Harrison TN; Sung SH; Reynolds K
    Mayo Clin Proc Innov Qual Outcomes; 2022 Jun; 6(3):218-227. PubMed ID: 35539894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.